Parameter | MC | DALWUH | CPC | ||
---|---|---|---|---|---|
Males | Males | Females | Males | Females | |
Physical characteristics | n = 175 | n = 41 | n = 59 | n = 320 | n = 370 |
Age (years) | 57.9 ± 0.3a, b | 56.6 ± 5.1b | 56.8 ± 5.1b | 50.1 ± 0.8 | 50.1 ± 0.8 |
Height (m) | 1.792 ± 0.067 | 1.777 ± 0.085 | 1.653 ± 0.063b | 1.800 ± 0.064 | 1.672 ± 0.060 |
Weight (kg) | 85.7 ± 14.7 | 83.7 ± 14.3c | 71.5 ± 14.4 | 86.9 ± 15.0c | 71.1 ± 14.1 |
Body Mass Index (kg*m−2) | 26.7 ± 4.1 | 26.5 ± 4.2 | 26.1 ± 4.8 | 26.8 ± 4.3c | 25.4 ± 4.9 |
Body Fat (%) | 22.6 ± 5.8 | 21.4 ± 6.7c | 32.5 ± 6.8 | 21.3 ± 6.3c | 31.4 ± 6.9 |
Physical activity (24-hour MET score) | 38.8 (36.9–42.4)b | 39.8 (37.3–44.6) | 38.6 (36.5–40.7)b | 40.1 (37.4–43.3) | 39.3 (37.7–42.2) |
Maximal Grip Strength (kg) | 48.4 ± 8.0b | 50.4 ± 7.6c | 31.1 ± 5.4b | 52.3 ± 8.6c | 32.6 ± 5.1 |
Fatigue Resistance (sec) | 33.4 (24.3–44.6) | 35.2 (26.9–46.1) | 33.7 (20.4–48.6) | 34.7 (27.0-47.2) | 36.4 (25.5–53.7) |
Grip Work (kg*sec) | 1264.8b (874.7-1625.6) | 1287.7 (983.2-1858.3) | 814.2 (467.0-1085.3) | 1375.9c (1028.2-1841.7) | 897.1 (600.4-1266.3) |
Grip Work /body mass (kg*sec*kg−1) | 14.4 (10.5–19.5) | 16.4 (11.9–21.5)c | 11.5 (5.7–18.2) | 16.4 (11.6–21.8)c | 12.4 (8.0-19.3) |
Self-perceived fatigue (MFI-20) | n = 159 | n = 37 | n = 56 | n = 311 | n = 366 |
Total Fatigue score (score 20–100) | 46 (36–55)a, b | 38 (31–45) | 39 (31–53) | 36 (30–46)c | 41 (31–52) |
CPV ratio | n = 159 | n = 37 | n = 56 | n = 311 | n = 366 |
CPV- Total Fatigue ratio | 28,58b (19,93 − 40,98) | 32,36c (22,82 − 54,67) | 17,97 (12,61 − 31,73 | 38,39c (26,05–51,62) | 22,07 (12,49 − 35,67) |
Inflammatory conditions(y/n) | 115/60 | 22/19 | 36/23 | 179/140 | 201/168 |
Acute systemic inflammatory event (y/n) | 74/101 | 15/26 | 24/35 | 118/201 | 134/235 |
Auto-immune disease or arthritis (y/n) | 55/120 | 8/33 | 16/43 | 66/254 | 87/283 |
Lung disease (y/n) | 27/148 | 5/36 | 7/52 | 37/283 | 47/323 |
Chronic viral infection (y/n) | 0/175 | 1/40 | 0/59 | 3/316 | 2/367 |
Inflammatory parameters | n = 169 | n = 41 | n = 59 | n = 316 | n = 363 |
hs-CRP (mg/L) | 1.0 (0.5–2.3) | 1.0 (0.5–2.5) | 1.2 (0.5–2.4) | 1.1 (0.5–2.3) | 0.9 (0.5–2.1) |
IFN-γ (pg/mL) | 0.43 (0.30–0.63) | 0.44 (0.32–0.81) | 0.45 (0.34–0.58) | 0.40 (0.28–0.66) | 0.40 (0.28–0.58) |
IL-6 (pg/mL) | 2.01 (1.37–3.55)b | 1.85 (1.16–3.01) | 1.86 (1.27–2.65) | 1.47 (1.01–2.28) | 1.46 (1.02–2.34) |
IL-10 (pg/mL) | 1.29 (0.80–2.06) | 1.34 (0.84–2.98) | 1.00 (0.60–2.22) | 1.05 (0.65–1.88) | 0.91 (0.53–1.79) |
TNF-alpha (pg/mL) | 4.74 (4.02–6.02) | 5.19 (4.46–6.24) | 4.22 (3.56–5.40) | 4.58 (3.38–5.59)c | 4.13 (3.47–5.22) |